These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 34302959)
1. Microbes in gynecologic cancers: Causes or consequences and therapeutic potential. Wahid M; Dar SA; Jawed A; Mandal RK; Akhter N; Khan S; Khan F; Jogaiah S; Rai AK; Rattan R Semin Cancer Biol; 2022 Nov; 86(Pt 2):1179-1189. PubMed ID: 34302959 [TBL] [Abstract][Full Text] [Related]
2. The microbiome and gynaecological cancer development, prevention and therapy. Łaniewski P; Ilhan ZE; Herbst-Kralovetz MM Nat Rev Urol; 2020 Apr; 17(4):232-250. PubMed ID: 32071434 [TBL] [Abstract][Full Text] [Related]
3. Potential contribution of the uterine microbiome in the development of endometrial cancer. Walther-António MR; Chen J; Multinu F; Hokenstad A; Distad TJ; Cheek EH; Keeney GL; Creedon DJ; Nelson H; Mariani A; Chia N Genome Med; 2016 Nov; 8(1):122. PubMed ID: 27884207 [TBL] [Abstract][Full Text] [Related]
4. Vaginal microbiota and gynecological cancers: a complex and evolving relationship. Javadi K; Ferdosi-Shahandashti E; Rajabnia M; Khaledi M Infect Agent Cancer; 2024 Jun; 19(1):27. PubMed ID: 38877504 [TBL] [Abstract][Full Text] [Related]
5. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Chase D; Goulder A; Zenhausern F; Monk B; Herbst-Kralovetz M Gynecol Oncol; 2015 Jul; 138(1):190-200. PubMed ID: 25957158 [TBL] [Abstract][Full Text] [Related]
6. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. Doerflinger SY; Throop AL; Herbst-Kralovetz MM J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560 [TBL] [Abstract][Full Text] [Related]
7. The microbiome and gynecologic cancer: cellular mechanisms and clinical applications. Chalif J; Wang H; Spakowicz D; Quick A; Arthur EK; O'Malley D; Chambers LM Int J Gynecol Cancer; 2024 Feb; 34(2):317-327. PubMed ID: 38088183 [TBL] [Abstract][Full Text] [Related]
8. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota]. Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257 [No Abstract] [Full Text] [Related]
9. The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities. Chambers LM; Bussies P; Vargas R; Esakov E; Tewari S; Reizes O; Michener C Curr Oncol Rep; 2021 Jun; 23(8):92. PubMed ID: 34125319 [TBL] [Abstract][Full Text] [Related]
10. Harnessing the power within: engineering the microbiome for enhanced gynecologic health. Brennan C; Chan K; Kumar T; Maissy E; Brubaker L; Dothard MI; Gilbert JA; Gilbert KE; Lewis AL; Thackray VG; Zarrinpar A; Knight R Reprod Fertil; 2024 Apr; 5(2):. PubMed ID: 38513356 [TBL] [Abstract][Full Text] [Related]
11. The role of the vaginal microbiome in gynaecological cancer. Champer M; Wong AM; Champer J; Brito IL; Messer PW; Hou JY; Wright JD BJOG; 2018 Feb; 125(3):309-315. PubMed ID: 28278350 [TBL] [Abstract][Full Text] [Related]
12. Pilot Study of Vaginal Microbiome Using QIIME 2™ in Women With Gynecologic Cancer Before and After Radiation Therapy. Bai J; Jhaney I; Daniel G; Watkins Bruner D Oncol Nurs Forum; 2019 Mar; 46(2):E48-E59. PubMed ID: 30767956 [TBL] [Abstract][Full Text] [Related]
13. Cervicovaginal Microbiome Composition Is Associated with Metabolic Profiles in Healthy Pregnancy. Oliver A; LaMere B; Weihe C; Wandro S; Lindsay KL; Wadhwa PD; Mills DA; Pride DT; Fiehn O; Northen T; de Raad M; Li H; Martiny JBH; Lynch S; Whiteson K mBio; 2020 Aug; 11(4):. PubMed ID: 32843557 [TBL] [Abstract][Full Text] [Related]
14. Changes in the Vaginal Microbiome and Associated Toxicities Following Radiation Therapy for Gynecologic Cancers. Tsementzi D; Meador R; Eng T; Patel P; Shelton J; Arluck J; Scott I; Dolan M; Khanna N; Konstantinidis KT; Bruner DW Front Cell Infect Microbiol; 2021; 11():680038. PubMed ID: 34778097 [TBL] [Abstract][Full Text] [Related]
15. Vaginal Dysbiotic Microbiome in Women With No Symptoms of Genital Infections. Pramanick R; Nathani N; Warke H; Mayadeo N; Aranha C Front Cell Infect Microbiol; 2021; 11():760459. PubMed ID: 35096634 [TBL] [Abstract][Full Text] [Related]
17. Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy. Cocomazzi G; Del Pup L; Contu V; Maggio G; Parmegiani L; Ciampaglia W; De Ruvo D; Faioli R; Maglione A; Baldini GM; Baldini D; Pazienza V Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396914 [TBL] [Abstract][Full Text] [Related]
18. Regulation of Vaginal Microbiome by Nitric Oxide. Yeruva T; Lee CH Curr Pharm Biotechnol; 2019; 20(1):17-31. PubMed ID: 30727888 [TBL] [Abstract][Full Text] [Related]
19. Human microbial dysbiosis as driver of gynecological malignancies. Mandal S; Bandyopadhyay S; Tyagi K; Roy A Biochimie; 2022 Jun; 197():86-95. PubMed ID: 35176353 [TBL] [Abstract][Full Text] [Related]
20. A Capillary Electrophoresis Method for Analyzing the Diversity of Vaginal Microbiome. Lai L; Wu Y; Li Y; Huang Y Clin Lab; 2022 Mar; 68(3):. PubMed ID: 35254031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]